http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4#Head http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4 http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4#assertion http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4 http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4#provenance http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4 http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4#pubInfo http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4#assertion http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4#assertion http://www.w3.org/ns/prov#wasGeneratedBy S&T TWOC project version 1 http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4#version http://www.w3.org/ns/prov#value 1 http://www.w3.org/1999/02/22-rdf-syntax-ns#object https://uts.nlm.nih.gov/uts/umls/concept/C1947944 use http://www.w3.org/1999/02/22-rdf-syntax-ns#object https://uts.nlm.nih.gov/uts/umls/concept/C5383282 convalescent plasma therapy http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate http://twoc-nlp-database-server-1:8555/solr/predicates/select?q=TRIPLE_UID:fv8lr3bm-TRIPLE-ABSTRACT-11 call http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C0003241 antibody http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C0005841 transfusion http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C0011777 dexamethasone http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C0021027 antibody http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C1167408 antibody http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C1621287 antibody http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C1879316 transfusion http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C3665580 antibody http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C5203670 COVID-19 http://www.w3.org/2000/01/rdf-schema#Triple-UID http://twoc-nlp-database-server-1:8555/solr/triples/select?q=TRIPLE_UID:fv8lr3bm-TRIPLE-ABSTRACT-11 fv8lr3bm-TRIPLE-ABSTRACT-11 http://www.w3.org/2000/01/rdf-schema#sentence http://www.w3.org/2000/01/rdf-schema#label Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus is responsible for the current pandemic - coronavirus disease 2019 (COVID)-19) plaguing the world Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus began spreading as early as January 2020 in the United States (US) and has recently become the leading cause of death amongst adults over 45 years of age Much of Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus's clinical presentation is already known, and there have been advances in Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus's successful treatment with a food and drug administration (FDA) approved antiviral medication called remdesivir, and other proven investigational methods with clinical benefits including dexamethasone and Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus antibody transfusion called convalescent plasma therapy However, the recommendations for other proven investigational methods with clinical benefits including dexamethasone and COVID-19 antibody transfusion called convalescent plasma therapy's use include COVID-19 confirmed patients requiring supplemental oxygen or other forms of respiratory support In this case report, we describe in detail a unique case of severe Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus infection that did not require any form of oxygen support hut was treated successfully with antiviral medications and steroids The purpose of this case report is to highlight in detail an unusual Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus presentation with rhabdomyolysis, myocarditis, and pancytopenia severe enough to require hospitalization and treatment with proven Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus therapy to achieve clinical resolution http://www.w3.org/2000/01/rdf-schema#triple http://www.w3.org/2000/01/rdf-schema#label dexamethasone and COVID-19 antibody transfusion called convalescent plasma therapy s use http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4#provenance http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4#assertion http://www.w3.org/ns/prov#generatedAtTime 2021-07-25T21:47:44.864391 http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4#pubInfo http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4#sig http://purl.org/nanopub/x/hasSignature GlZA70ScsPN63HJ5hL65ON/Gg1tCXHstoPc37eO3NjZswFlYu6CIOp6XzBctxIBqDEHskPkp6Lvx5ljJ8M8jcUJxhJAHVGDamm8Hz9cCo6KdsEWcKsHz2eH0pOXqrtc0sNMjGbHTe8B58WzctRMVIk0fTMd4ro35ZIQaZeqyeUA= http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4 http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4 http://www.w3.org/ns/prov#generatedAtTime 2021-07-25T21:47:44.864391 http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4 http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-8954-0470